ChemicalBook--->CAS DataBase List--->103890-78-4

103890-78-4

103890-78-4 Structure

103890-78-4 Structure
IdentificationMore
[Name]

Lacidipine
[CAS]

103890-78-4
[Synonyms]

CALDINE
(E)-4-[2-[3-(1,1-DIMETHYLETHOXY)-3-OXO-1-PROPENYL]PHENYL]-1,4-DIHYDRO-2,6-DIMETHYL-3,5-PYRIDINEDICARBOXYLIC ACID DIETHYL ESTER
GR-43659X
GX-1048
LACIDIPINE
LACIDIPINE-D9
LACIPIL
LACIREX
MOTENS
3,5-pyridinedicarboxylicacid,1,4-dihydro-2,6-dimethyl-4-(2-(3-(1,1-dimethylet
diethylester,(e)-hoxy)-3-oxo-1-propenyl)phenyl)
Lacidipin
LACIDIPINE, IMPURITY STANDARD BP STANDARD
LACIDIPINE, BP STANDARD
LACIDIPINE ASSAY STANDARD BP(CRM STANDARD)
LACIDIPINE BP STANDARD(CRM STANDARD)
LACIDIPINE IMPURITY STANDARD BP STANDARD(CRM STANDARD)
LACIDIPINE IMPURITY STANDARD BP(CRM STANDARD)
LacidipineC26H33N06
(E)-4-[2-[3-(1,1-Dimethylethoxy)-3-oxo-1-propenyl]phenyl]-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic Acid Diethyl Ester, GR-43659X, GX-1048, Caldine, Lacipil, Lacirex, Motens
[EINECS(EC#)]

638-759-0
[Molecular Formula]

C26H33NO6
[MDL Number]

MFCD00865936
[Molecular Weight]

455.54
[MOL File]

103890-78-4.mol
Chemical PropertiesBack Directory
[Appearance]

White-to-Off-White Crystalline Solid
[Melting point ]

174-175°C
[Boiling point ]

558.4±50.0 °C(Predicted)
[density ]

1.127±0.06 g/cm3(Predicted)
[storage temp. ]

2-8°C
[solubility ]

DMSO: soluble20mg/mL, clear
[form ]

powder
[pka]

3.00±0.70(Predicted)
[color ]

white to beige
[Usage]

A dihydropyridine calcium channel blocker. Antihypertensive
[Merck ]

14,5331
[InChI]

InChI=1S/C26H33NO6/c1-8-31-24(29)21-16(3)27-17(4)22(25(30)32-9-2)23(21)19-13-11-10-12-18(19)14-15-20(28)33-26(5,6)7/h10-15,23,27H,8-9H2,1-7H3/b15-14+
[InChIKey]

GKQPCPXONLDCMU-CCEZHUSRSA-N
[SMILES]

C1(C)NC(C)=C(C(OCC)=O)C(C2=CC=CC=C2/C=C/C(OC(C)(C)C)=O)C=1C(OCC)=O
[CAS DataBase Reference]

103890-78-4(CAS DataBase Reference)
Safety DataBack Directory
[Hazard Codes ]

Xn
[Risk Statements ]

22
[WGK Germany ]

3
[RTECS ]

US7970200
[Storage Class]

11 - Combustible Solids
[Hazard Classifications]

Acute Tox. 4 Oral
[Toxicity]

mouse,LD50,intraperitoneal,80200ug/kg (80.2mg/kg),SKIN AND APPENDAGES (SKIN): HAIR: OTHERSENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYEBEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY),Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 22, Pg. 335, 1994.
Raw materials And Preparation ProductsBack Directory
[Raw materials]

Triphenylphosphine-->trans-Cinnamic acid-->tert-Butyl acetate-->o-Phthalaldehyde-->tert-Butyl acrylate-->(tert-Butoxycarbonylmethyl)triphenylphosphanium bromide-->ETHYL 3-AMINOCROTONATE-->Sodium hydroxide-->Isopropyl alcohol
Material Safety Data Sheet(MSDS)Back Directory
[msds information]

Lacidipine(103890-78-4).msds
Hazard InformationBack Directory
[Description]

Lacidipine is a new second-generation dihydropyridine calcium antagonist introduced as a once a day treatment for mild to moderate hypertension. It is reported to have high selectivity for vascular smooth muscle and also a long duration of action. The use of lacidipine as an antiatherosclerotic agent is currently under investigation.
[Chemical Properties]

White-to-Off-White Crystalline Solid
[Originator]

Glaxo (United Kingdom)
[Uses]

A dihydropyridine calcium channel blocker. Antihypertensive
[Uses]

antihypertensive;dihydropyridinr calcium channel blocker
[Definition]

ChEBI: Lacidipine is a cinnamate ester and a tert-butyl ester.
[Brand name]

Lacipil; Lacirex; Viapres
[Biochem/physiol Actions]

Lacidipine is a long-acting calcium antagonist that is used in the management of hypertension. Lacidipine is a L-type Ca(2+) channel blocker belonging to 1,4-dihydropyridine class. Also, Lacidipine inhibits ryanodine receptors on the ER membrane that enhances folding, trafficking and lysosomal activity of ERAD (ER-associated degradation) misfolded lysosomal glucocerebrosidase (GS).
[Clinical Use]

#N/A
[Synthesis]

(tert-Butoxycarbonylmethyl)triphenylphosphanium bromide

59159-39-6

ETHYL 3-AMINOCROTONATE

626-34-6

o-Phthalaldehyde

643-79-8

Lacidipine

103890-78-4

1. 18 liters of dichloromethane were added to the reactor, followed by 5 kg of tert-butoxycarbonylmethyltriphenylphosphonium bromide (prepared with reference to Example 1). 2. 2.05 kg of o-phthalaldehyde was added, followed by 1 liter of dichloromethane, and the mixture was stirred for about 15 minutes, then cooled to -5°C. 3. A solution of 2.65 kg of sodium hydroxide flakes in 5 liters of water (pre-prepared at 25°C) was added to the reaction mixture at -3°C and kept at -3°C for 2.5 hours. The reaction process was monitored by thin layer chromatography. 4. After completion of the reaction, the mixture was warmed up to 25°C and stirring was continued for 30 minutes. The organic layer was separated and the solvent was removed by atmospheric pressure distillation at 52°C. The residue was kept at 52°C for 15 minutes. 5. 35 liters of n-heptane were added and 4 liters of n-heptane were distilled under 500 mmHg vacuum and at 63 °C. The mixture was then cooled to 0°C and held at 35°C for 1.5 hours. 6. The insoluble material was removed by vacuum filtration and the filter cake was washed with 7.5 liters of n-heptane. The filtrate was transferred to another reactor and the solvent was removed by complete distillation under vacuum at 610 mmHg and 68°C. 7. Cooled to 33 °C, 11.5 liters of isopropanol was added and subsequently cooled to -7 °C. 8. At -7 °C, a solution of 4.25 kg ethyl 3-aminocrotonate in 12.5 liters of isopropanol was slowly added, followed by 2.8 liters of trifluoroacetic acid and 1 liter of isopropanol, and the reaction was kept at -7 °C for 2 hours and 45 minutes. The reaction process was monitored by thin layer chromatography. 9. A solution of 2.6 kg of sodium bicarbonate in 50 liters of water was added to the reaction mixture at 0 °C, followed by 25 liters of ethyl acetate. Increase the temperature to 25°C and stir for 20 minutes. Separate the aqueous layer and extract with 12.5 liters of ethyl acetate. The organic layers were combined and the solvent was removed by atmospheric pressure distillation at 81 °C. 10. Add 5 liters of isopropanol to the residue and distill completely to remove the solvent. This operation is repeated once. Finally, the residue was dissolved in 63 liters of isopropanol and heated to 85°C to obtain a clarified solution. 11. Cool to 2 °C, keep for 1.5 h. Separate the solid by filtration and wash with 2.5 liters of isopropanol. The wet product was dried at 50°C for 30 minutes. 12. The dried substance was added to 23 liters of isopropanol, heated to 65°C and held for 30 minutes, cooled to 2°C and held for 1 hour, filtered and washed with 1.5 liters of isopropanol. 13. The wet solid was dried at 60 °C and 630 mmHg under vacuum for 5 h to give 2.04 kg of ethyl (E)-diethyl 4-(2-(3-(tert-butoxy)-3-oxoprop-1-en-1-yl)phenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate in 40.9% yield. The content of triphenylphosphine oxide was less than 0.0011 area%.

[Drug interactions]

Potentially hazardous interactions with other drugs Aminophylline and theophylline: possibly increased aminophylline and theophylline concentration. Anaesthetics: enhanced hypotensive effect. Antibacterials: metabolism possibly inhibited by clarithromycin, erythromycin and telithromycin. Antidepressants: enhanced hypotensive effect with MAOIs. Antiepileptics: effect possibly reduced by carbamazepine, barbiturates, phenytoin and primidone. Antifungals: metabolism possibly inhibited by itraconazole and ketoconazole; negative inotropic effect possibly increased with itraconazole. Antihypertensives: enhanced hypotensive effect, increased risk of first dose hypotensive effect of postsynaptic alpha-blockers. Antivirals: concentration possibly increased by ritonavir. Ciclosporin: 10 kidney transplant patients on ciclosporin, prednisone and azathioprine were given 4 mg lacidipine daily. A very small increase in the trough serum levels (+6%) and AUC (+14%) of the ciclosporin occurred. Grapefruit juice: concentration increased - avoid concomitant use
[Metabolism]

Lacidipine undergoes extensive first-pass metabolism in the liver. The drug is eliminated primarily by hepatic metabolism (involving cytochrome P450 CYP3A4). The principal metabolites possess little, if any, pharmacodynamic activity. Approximately 70% of the administered dose is eliminated as metabolites in the faeces and the remainder as metabolites in the urine.
[References]

[1] Patent: US2007/43088, 2007, A1. Location in patent: Page/Page column 6
Spectrum DetailBack Directory
[Spectrum Detail]

Lacidipine(103890-78-4)1HNMR
103890-78-4 suppliers list
Company Name: Hubei Yuanmeng Biotechnology Co., Ltd  Gold
Telephone: 027-68897569 18120462897
Website:
Company Name: Wuhan Hongfuda New Materials Co., Ltd.  Gold
Telephone: 19107255884 19107255884
Website: www.chemicalbook.com/supplier/24406900/
Company Name: Hubei Weideli Chemical Reagent Co., Ltd.  Gold
Telephone: 13429867250 13429867250
Website: www.dxtyaoye.com
Company Name: Hubei Yuanmeng Biological Technology Co., Ltd.  Gold
Telephone: 027-68897569 18120462897
Website: www.chemicalbook.com/supplier/22947784/
Company Name: J & K SCIENTIFIC LTD.  
Telephone: 18210857532 18210857532
Website: https://www.jkchemical.com
Company Name: 3B Pharmachem (Wuhan) International Co.,Ltd.  
Telephone: 18930552037
Website: www.chemicalbook.com/showsupplierproductslist13285/0_en.htm
Company Name: TCI (Shanghai) Development Co., Ltd.  
Telephone: 021-67121386
Website: https://www.tcichemicals.com/CN/zh/
Company Name: Beijing HwrkChemical Technology Co., Ltd  
Telephone: 89508211 18501085097
Website: http://www.hwrkchemical.com
Company Name: Energy Chemical  
Telephone: 400-0056266
Website: www.energy-chemical.com
Company Name: Adamas Reagent, Ltd.  
Telephone: 400-6009262 15618770481
Website: www.tansoole.com
Company Name: Chemsky(shanghai)International Co.,Ltd.  
Telephone: 021-50135380
Website: www.shchemsky.com
Company Name: XiaoGan ShenYuan ChemPharm co,ltd  
Telephone: 15527621225; 15527621225
Website: http://www.farchem.com/
Company Name: China Langchem Inc.  
Telephone: 0086-21-58956006
Website: www.chemicalbook.com/ShowSupplierProductsList19141/0_EN.htm
Company Name: Wuhan Fortuna Chemical Co., Ltd  
Telephone: 027-59207852 13308628970
Website: http://www.fortunachem.cn
Company Name: Dalian Meilun Biotech Co., Ltd.  
Telephone: 0411-62910999 13889544652
Website: http://www.meilunbio.com/
Company Name: T&W GROUP  
Telephone: 021-61551611 13296011611
Website: www.trustwe.com/
Company Name: Shanghai civi chemical technology co.,Ltd  
Telephone: 86-21-34053660
Website: www.labgogo.com
Company Name: Beijing HuaMeiHuLiBiological Chemical   
Telephone: 010-56205725
Website: www.huabeibiochem.com
Tags:103890-78-4 Related Product Information
76-87-9 3332-29-4 118-55-8 91-53-2 462-95-3 101-84-8 103-82-2 7782-44-7 103890-78-4